{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:45:57Z","timestamp":1790736357303,"version":"4.1.0"},"reference-count":31,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,2,3]]},"published-print":{"date-parts":[[2025,4]]},"DOI":"10.2967\/jnumed.124.268835","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T16:15:23Z","timestamp":1740672923000},"page":"552-558","source":"Crossref","is-referenced-by-count":9,"title":["Development and Preclinical Evaluation of [<sup>64<\/sup>Cu]Cu-NOTA-ABDB6: A CD70 and Albumin Dual-Binding Tracer with Improved Pharmacokinetics"],"prefix":"10.2967","volume":"66","author":[{"given":"Xiaoyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Mixdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Engle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd E.","family":"Barnhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon C.","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"2025040211001546000_66.4.552.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2016.07.012"},{"key":"2025040211001546000_66.4.552.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2005.02.002"},{"key":"2025040211001546000_66.4.552.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-293050"},{"key":"2025040211001546000_66.4.552.4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/joim.12813","article-title":"FDG\u2010PET\/CT in the management of lymphomas: current status and future directions","volume":"284","author":"El\u2010Galaly","year":"2018","journal-title":"J Intern Med."},{"key":"2025040211001546000_66.4.552.5","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.9b00738"},{"key":"2025040211001546000_66.4.552.6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007515"},{"key":"2025040211001546000_66.4.552.7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/hon.3013","article-title":"Targeting CD19 in diffuse large B\u2010cell lymphoma: an expert opinion paper","volume":"40","author":"Bailly","year":"2022","journal-title":"Hematol Oncol."},{"key":"2025040211001546000_66.4.552.8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40364-021-00309-5","article-title":"Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma","volume":"9","author":"Yin","year":"2021","journal-title":"Biomark Res."},{"key":"2025040211001546000_66.4.552.9","doi-asserted-by":"crossref","first-page":"1363102","DOI":"10.3389\/fimmu.2024.1363102","article-title":"Advancements in cancer immunotherapies targeting CD20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells","volume":"15","author":"Dabkowska","year":"2024","journal-title":"Front Immunol."},{"key":"2025040211001546000_66.4.552.10","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1508624"},{"key":"2025040211001546000_66.4.552.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264816"},{"key":"2025040211001546000_66.4.552.12","doi-asserted-by":"publisher","DOI":"10.1385\/IR:21:1:23"},{"key":"2025040211001546000_66.4.552.13","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02215-y"},{"key":"2025040211001546000_66.4.552.14","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003289"},{"key":"2025040211001546000_66.4.552.15","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3390\/cancers11101611","article-title":"Screening a broad range of solid and haematological tumour types for CD70 expression using a uniform IHC methodology as potential patient stratification method","volume":"11","author":"Flieswasser","year":"2019","journal-title":"Cancers (Basel)."},{"key":"2025040211001546000_66.4.552.16","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281563"},{"key":"2025040211001546000_66.4.552.17","doi-asserted-by":"crossref","first-page":"100824","DOI":"10.1016\/j.currproblcancer.2021.100824","article-title":"Emerging immuno-oncology targets in myelodysplastic syndromes (MDS)","volume":"46","author":"Mann","year":"2022","journal-title":"Curr Probl Cancer."},{"key":"2025040211001546000_66.4.552.18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0613"},{"key":"2025040211001546000_66.4.552.19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41181-023-00194-3","article-title":"Site-specific 68Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models","volume":"8","author":"Dewulf","year":"2023","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2025040211001546000_66.4.552.20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.eururo.2024.06.020","article-title":"[18F]RCCB6 immuno-positron emission tomography\/computed tomography for postoperative surveillance in clear cell renal cell carcinoma: a pilot clinical study","volume":"86","author":"Wu","year":"2024","journal-title":"Eur Urol."},{"key":"2025040211001546000_66.4.552.21","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1007\/s00259-024-06672-3","article-title":"ImmunoPET\/CT imaging of clear cell renal cell carcinoma with [18F]RCCB6: a first-in-human study","volume":"51","author":"Wu","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025040211001546000_66.4.552.22","doi-asserted-by":"publisher","DOI":"10.5936\/csbj.201303009"},{"key":"2025040211001546000_66.4.552.23","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1185581"},{"key":"2025040211001546000_66.4.552.24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13550-020-0599-1","article-title":"On the prevention of kidney uptake of radiolabeled DARPins","volume":"10","author":"Altai","year":"2020","journal-title":"EJNMMI Res."},{"key":"2025040211001546000_66.4.552.25","doi-asserted-by":"crossref","first-page":"100796","DOI":"10.1016\/j.currproblcancer.2021.100796","article-title":"Monoclonal antibody based radiopharmaceuticals for imaging and therapy","volume":"45","author":"Lin","year":"2021","journal-title":"Curr Probl Cancer."},{"key":"2025040211001546000_66.4.552.26","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0493"},{"key":"2025040211001546000_66.4.552.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2011.10.014"},{"key":"2025040211001546000_66.4.552.28","doi-asserted-by":"crossref","first-page":"e1118","DOI":"10.1002\/ctm2.1118","article-title":"The dual role of CD70 in B\u2010cell lymphomagenesis","volume":"12","author":"Nie","year":"2022","journal-title":"Clin Trans Med."},{"key":"2025040211001546000_66.4.552.29","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-05-0253"},{"key":"2025040211001546000_66.4.552.30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.omto.2022.11.003","article-title":"Development and comparison of 68Ga\/18F\/64Cu-labeled nanobody tracers probing Claudin18.2","volume":"27","author":"Wei","year":"2022","journal-title":"Mol Ther Oncolytics."},{"key":"2025040211001546000_66.4.552.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1930-x"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.268835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T18:18:41Z","timestamp":1743617921000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.268835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,1]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.2967\/jnumed.124.268835"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.268835","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}